The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality
Abstract
OBJECTIVE: To determine the incidence, clinical course, and risk factors associated with the onset of chronic renal failure in sickle cell anemia and sickle C disease. DESIGN: A prospective, 25-year longitudinal demographic and clinical cohort study. A matched case-control study was conducted to determine risk factors. PATIENTS: A total of 725 patients with sickle cell anemia and 209 patients with sickle C disease who received medical care from the hematology service in a large municipal hospital. Most were observed from birth or early childhood. MEASUREMENTS: Thirty-six patients developed sickle renal failure: 4.2% of patients with sickle cell anemia and 2.4% of patients with sickle C disease. The median age of disease onset for these patients was 23.1 and 49.9 years, respectively. Survival time for patients with sickle cell anemia after the diagnosis of sickle renal failure, despite dialysis, was 4 years, and the median age at the time of death was 27 years. Relative risk for mortality was 1.42 (95% Cl, 1.12 to 1.81; P = 0.02) compared with patients who did not develop renal insufficiency. MAIN RESULTS: Histopathologic studies showed characteristic lesions of glomerular "drop out" and glomerulosclerosis. Case-control analysis showed that ineffective erythropoiesis with increasingly severe anemia, hypertension, proteinuria, the nephrotic syndrome, and microscopic hematuria were significant pre-azotemic predictors of chronic renal failure. The risk for sickle renal failure was increased in patients who had inherited the Central African Republic beta s-gene cluster haplotype. CONCLUSIONS: The pre-azotemic manifestations of hypertension, proteinuria, and increasingly severe anemia predict end-stage renal failure in patients with sickle cell disease. The rate of progression of renal insufficiency is genetically determined. Treatment of the uremic phase has been dismal, underscoring the need for the development of useful pre-azotemic therapeutic modalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Epstein, F. H., Brenner, B. M., Meyer, T. W., & Hostetter, T. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209093071104 · Cited by 2,075
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., & Adamson, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701083160203 · Cited by 2,005
Report of the Second Task Force on Blood Pressure Control in Children—1987
Task Force on Blood Pressure Control in Children (1987) · Pediatrics · doi:10.1542/peds.79.1.1 · Cited by 1,148
Report of the second Task Force on Blood Pressure Control in Children―1987
Horan, M. J. (1987) · PEDIATRICS · Cited by 1,125
The Progression of Renal Disease
Epstein, F. H., Klahr, S., Schreiner, G., & Ichikawa, I. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806233182505 · Cited by 828
Statistical Methods for Rates and Proportions.
Fielding, A., & Fleiss, J. L. (1974) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344565 · Cited by 767
The natural history of stroke in sickle cell disease
Powars, D., Wilson, B., Imbus, C., Pegelow, C., & Allen, J. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90772-6 · Cited by 594
Self-citationHemoglobin S gelation and sickle cell disease
Eaton, W., & Hofrichter, J. (1987) · Blood · doi:10.1182/blood.v70.5.1245.1245 · Cited by 425
Research works printed but not linked: 28
- 10.1172/JCI113504 · doi:10.1172/jci113504
- Nissenson A, 1989, Q J Med., 73, 1055
- 10.1016/S0272-6386(12)80082-5 · doi:10.1016/s0272-6386(12)80082-5
- 10.1097/00007611-193410000-00003 · doi:10.1097/00007611-193410000-00003
- 10.1097/00000441-198005000-00006 · doi:10.1097/00000441-198005000-00006
- 10.1159/000183848 · doi:10.1159/000183848
- Cruz I, 1982, J Natl Med Assoc., 74, 1103
- 10.1056/NEJM197408292910902 · doi:10.1056/nejm197408292910902
- Gonzalez-Carrillo M, 1982, Clin Nephrol., 18, 209
- Chatterjee S, 1987, Transplant Proc., 19, 33
- Westney L, 1984, Obstet Gynecol., 63, 752
- McCoy R, 1969, Lab Invest., 21, 85
- 10.1016/0002-9343(78)90524-7 · doi:10.1016/0002-9343(78)90524-7
- Powars D, 1975, Semin Hematol., 12, 267
- Schroeder W, 1980, The Chromatography of Hemoglobin.
- Nagel R, 1990, Semin Hematol., 27, 342
- 10.1001/jama.1968.03140130047014 · doi:10.1001/jama.1968.03140130047014
- 10.1038/ki.1976.93 · doi:10.1038/ki.1976.93
- Coe F, 1976, The Kidney., 767
- 10.1203/00006450-198803000-00008 · doi:10.1203/00006450-198803000-00008
- Mantel N, 1959, J Natl Cancer Inst., 22, 719
- 10.1093/ije/15.2.257 · doi:10.1093/ije/15.2.257
- Mehta C, 1985, J Am Stat Assoc., 80, 969
- Powars D, 1990, Semin Hematol., 27, 360
- Nduke N, 1987, Folia Haematol (Leipz)., 114, 508
- Haddy T, 1982, Am J Pediatr Hematol Oncol., 4, 191
- 10.1111/j.1365-2141.1988.tb02497.x · doi:10.1111/j.1365-2141.1988.tb02497.x
- 10.1016/S0272-6386(87)80027-6 · doi:10.1016/s0272-6386(87)80027-6
Cited by
Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.10517 · Cited by 1,599
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Intravascular hemolysis and the pathophysiology of sickle cell disease
Kato, G. J., Steinberg, M. H., & Gladwin, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89741 · Cited by 748
Bone Marrow Transplantation for Sickle Cell Disease
Walters, M. C., Patience, M., Leisenring, W., Eckman, J. R., Scott, J. P., Mentzer, W. C., Davies, S. C., Ohene-Frempong, K., Bernaudin, F., Matthews, D. C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350601 · Cited by 627
Metadata
- Authors
- Powars, D. R., Elliott-Mills, D. D., Chan, L., Niland, J., Hiti, A. L., Opas, L. M., & Johnson, C.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1991-10-15
- Volume
- 115
- Issue
- 8
- Pages
- 614-620
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2049661833
- Cited by
- 360
- References
- 48
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality. https://app.cochat.ai/papers/10.7326/0003-4819-115-8-614
- The paper
- Powars, D. R., Elliott-Mills, D. D., Chan, L., Niland, J., Hiti, A. L., Opas, L. M., & Johnson, C. (1991). Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-115-8-614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.